🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

9,250 results for “IO” Clear

  1. Minoxidil lotion 2%

    Hospital Authority, Hong Kong

    Hypotrichosis of Eyebrows

    approved small molecule completed

    1 trial

  2. Mitapivat

    Agios Netherlands B.V.

    Pyruvate Kinase Deficiency

    approved small molecule active

    2 trials

  3. Mobile Surgical Vehicle Echocardiography-guided ASD closure Group

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    ASD - Atrial Septal Defect

    approved other active

    1 trial

  4. Morfina cloridrato S.A.L.F. 10 mg/ml soluzione iniettabile, ROPIVACAINA CLORIDRATO BIOINDUSTRIA L.I.M. 10 mg/ml soluzione iniettabile, CATAPRESAN 150 microgrammi/ml soluzione iniettabile

    Istituto Gentili S.r.l.

    cesarean section

    approved small molecule active

    1 trial

  5. Morphine

    COLLEGIUM PHARMACEUTICAL, INC

    ST-segment Elevation Myocardial Infarction

    approved small molecule completed

    1 trial

  6. Morphine

    BRIGHT MINDS BIOSCIENCES INC.

    Chronic Pain

    approved small molecule terminated

    1 trial

  7. Mounjaro 5 mg solution for injection in pre-filled pen, Mounjaro 2.5 mg solution for injection in pre-filled pen

    The George Institute

    Obesity

    approved small molecule active

    1 trial

  8. Myocardial perfusion imaging

    Aspire Biopharma Holdings

    Coronary Artery Disease

    approved other completed

    1 trial

  9. Myozyme 50 mg powder for concentrate for solution for infusion

    Disc Medicine

    Pompe disease / glycogenosis type II / acid maltase deficiency

    approved small molecule active

    1 trial

  10. Myozyme 50 mg powder for concentrate for solution for infusion, Opfolda 65 mg hard capsules, Pombiliti 105 mg powder for concentrate for solution for infusion, Nexviadyme 100 mg powder for concentrate for solution for infusion

    Disc Medicine

    Pompe disease

    approved small molecule active

    1 trial

  11. Naglazyme

    BioMarin Pharmaceutical Australia Pty Ltd

    Mucopolysaccharidosis VI

    approved small molecule completed

    1 trial

  12. Naltrexone HCl/Bupropion HCl Placebo

    Takeda

    Weight Regain Post Bariatric Surgery

    approved small molecule terminated

    1 trial

  13. Neffy

    Ars Pharmaceuticals Irl Limited

    Allergic Reactions

    approved small molecule active

    1 trial

  14. Neovascular Age-related Macular Degeneration

    Novartis Pharmaceuticals

    Neovacular Age-related Macular Degeneration

    approved other completed

    1 trial

  15. Nexviadyme 100 mg powder for concentrate for solution for infusion

    Disc Medicine

    Glycogen storage disease type II or acid maltase deficiency, Pompe disease

    approved small molecule active

    1 trial

  16. Nexviadyme 100 mg powder for concentrate for solution for infusion, Nexviadyme 100 mg powder for concentrate for solution for infusion, Nexviadyme 100 mg powder for concentrate for solution for infusion, Nexviadyme 100 mg powder for concentrate for solution for infusion

    Sanofi Winthrop Industrie

    Glycogen storage disease type II

    approved small molecule active

    1 trial

  17. Nicotine

    BRIGHT MINDS BIOSCIENCES INC.

    Marijuana Dependence

    approved small molecule completed

    1 trial

  18. Nicotine Nasal Spray

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking Cessation

    approved small molecule completed

    1 trial

  19. Nicotine Patch

    BRIGHT MINDS BIOSCIENCES INC.

    Cigarette Smoking

    approved small molecule completed

    3 trials

  20. Nicotine patch

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    approved small molecule terminated

    3 trials

  21. Nicotine patch - transdermal

    BRIGHT MINDS BIOSCIENCES INC.

    Nicotine Dependence

    approved small molecule completed

    1 trial

  22. Nifedipine GITS

    The First People's Hospital of Lianyungang

    Hypertension

    approved small molecule active

    1 trial

  23. Norfloxacino Sandoz 400 mg comprimidos EFG

    The George Institute

    Hospitalized patients with decompensated cirrhosis, diagnosed with bacterial infection evolution lasting for 48 hours or less.

    approved small molecule active

    1 trial

  24. Normal saline

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    STEMI - ST Elevation Myocardial Infarction

    approved small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources